Physician profile
Ashok Y Reddy
NPI 1720069040
$4,890,183.64
in general payments reported to CMS, 2019-2025
46 companies · $6,293 in 2025
The $6,293 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $226 · 2021: $2.4M · 2022: $888K · 2023: $531K · 2024: $1.1M · 2025: $6,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1.6M · Food and Beverage: $4,207 · Travel and Lodging: $2,197 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,584,467.59 |
| Food and Beverage | $4,206.86 |
| Travel and Lodging | $2,196.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,879,428.39 | 2019-2025 | Axonics, Rezum Generator |
| Avyxa Pharma, LLC | $4,543.85 | 2025 | |
| Ferring Pharmaceuticals INC. | $519.19 | 2019-2025 | Adstiladrin |
| Janssen Biotech, INC. | $487.69 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $449.83 | 2019-2025 | Xtandi |
| Medtronic, INC. | $443.24 | 2021-2025 | Interstim |
| Myriad Genetic Laboratories, INC. | $340.68 | 2022-2025 | Prolaris |
| Abbvie INC. | $313.28 | 2019-2025 | |
| Axonics, INC. | $253.94 | 2022-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $247.22 | 2022-2023 | Aquabeam Robotic System |
| Calyxo, INC. | $243.72 | 2024-2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $186.55 | 2023-2025 | Jelmyto |
| Bioprotect Medical, INC. | $165.12 | 2025 | Bioprotect Balloon Implant System |
| Janssen Scientific Affairs, LLC | $163.61 | 2019-2024 | Pipeline, Erleada |
| Blue Earth Diagnostics | $159.96 | 2019-2025 | Posluma |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $153.73 | 2022-2023 | Speedicath |
| Sumitomo Pharma America, INC. | $151.61 | 2024-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $151.59 | 2019-2025 | Itind System |
| Neotract INC. | $138.40 | 2019 | |
| Teleflex LLC | $136.51 | 2023 | Urolift |
| Verity Pharmaceuticals INC. | $123.81 | 2025 | Tlando |
| Clarus Therapeutics INC. | $110.89 | 2020 | |
| Merck Sharp & Dohme LLC | $103.57 | 2022-2025 | Keytruda, Keytruda Qlex |
| Laborie Medical Technologies Corp. | $102.64 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $98.86 | 2019-2022 | |
| Histosonics, INC. | $93.79 | 2025 | |
| Pfizer INC. | $92.63 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $80.81 | 2023-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $76.29 | 2022 | |
| Ambu INC. | $71.76 | 2023 | |
| Urovant Sciences INC | $70.62 | 2021-2022 | |
| Photocure INC | $64.27 | 2023-2025 | Cysview |
| Allergan, INC. | $63.49 | 2020-2022 | |
| Amgen INC. | $46.25 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $41.36 | 2024 | |
| Endo USA, INC. | $40.98 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $38.34 | 2022-2023 | Xiaflex |
| 180 Medical, INC. | $37.87 | 2022-2024 | |
| Azurity Pharmaceuticals, INC. | $35.67 | 2025 | Azmiro |
| Medtronic USA, INC. | $32.90 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $21.69 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.80 | 2025 | Oxlumo |
| Tolmar, INC. | $16.05 | 2024 | |
| Metuchen Pharmaceuticals | $12.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$205,032.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.